Compounds > organophosphonates
Page last updated: 2024-09-05

organophosphonates and am 630

organophosphonates has been researched along with am 630 in 5 studies

Compound Research Comparison

Studies
(organophosphonates)		Trials
(organophosphonates)		Recent Studies (post-2010)
(organophosphonates)		Studies
(am 630)		Trials
(am 630)		Recent Studies (post-2010) (am 630)
9,9688803,5962811194

Protein Interaction Comparison

ProteinTaxonomyorganophosphonates (IC50)am 630 (IC50)
Cannabinoid receptor 2 Homo sapiens (human)7.2

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shimizu, T; Yokotani, K1
da Fonseca Pacheco, CM; da Fonseca Pacheco, D; de Castro Perez, A; de Francischi, JN; Duarte, ID; Klein, A1
Lewis, AW; Neuendorff, DA; Randel, RD; Weems, CW; Weems, YS1
Aguiar, DC; Cruz, JS; de Paula, AM; Di Marzo, V; Duarte, ID; Galdino, G; Parrella, C; Perez, AC; Piscitelli, F; Romero, TR; Silva, JF1
Duarte, IDG; Pacheco, DDF; Romero, TRL1

Other Studies

5 other study(ies) available for organophosphonates and am 630

ArticleYear
Bidirectional roles of the brain 2-arachidonoyl-sn-glycerol in the centrally administered vasopressin-induced adrenomedullary outflow in rats.
    European journal of pharmacology, 2008, Mar-17, Volume: 582, Issue:1-3

    Topics: Adrenal Medulla; Animals; Arachidonic Acids; Arginine Vasopressin; Benzoxazines; Brain; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Cannabinoid Receptor Modulators; Catecholamines; Cyclohexanones; Dose-Response Relationship, Drug; Endocannabinoids; Enzyme Inhibitors; Epinephrine; Glycerides; Indoles; Injections, Intraventricular; Male; Morpholines; Naphthalenes; Norepinephrine; Organophosphonates; Piperidines; Pyrazoles; Rats; Rats, Wistar

2008
The mu-opioid receptor agonist morphine, but not agonists at delta- or kappa-opioid receptors, induces peripheral antinociception mediated by cannabinoid receptors.
    British journal of pharmacology, 2008, Volume: 154, Issue:5

    Topics: Amidohydrolases; Analgesics, Opioid; Animals; Arachidonic Acids; Benzamides; Benzomorphans; Cannabinoid Receptor Modulators; Dinoprostone; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Hyperalgesia; Indoles; Male; Morphine; Organophosphonates; Pain; Pain Measurement; Piperazines; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu

2008
Endocannabinoid 1 and 2 (CB(1); CB(2)) receptor agonists affect negatively cow luteal function in vitro.
    Prostaglandins & other lipid mediators, 2009, Volume: 90, Issue:3-4

    Topics: Adenine; Adenosine; Animals; Arachidonic Acids; Cattle; Corpus Luteum; Dinoprost; Dinoprostone; Female; In Vitro Techniques; Indoles; Organophosphonates; Piperidines; Pregnancy; Progesterone; Pyrazoles; Pyrrolidines; Random Allocation; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2

2009
The endocannabinoid system mediates aerobic exercise-induced antinociception in rats.
    Neuropharmacology, 2014, Volume: 77

    Topics: Analgesia; Animals; Arachidonic Acids; Benzodioxoles; Brain; Cannabinoid Receptor Modulators; Endocannabinoids; Indoles; Male; Organophosphonates; Pain Measurement; Physical Conditioning, Animal; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1

2014
Ketamine induces central antinociception mediated by endogenous cannabinoids and activation of CB
    Neuroscience letters, 2019, 04-23, Volume: 699

    Topics: Analgesics; Animals; Arachidonic Acids; Cannabinoids; Dose-Response Relationship, Drug; Drug Synergism; Indoles; Infusions, Intraventricular; Ketamine; Male; Mice; Organophosphonates; Pain Measurement; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2

2019